companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

TRANSPLANT SUPPORT ORGANIZATION

NEW ROCHELLE-USA

Company Name:
Corporate Name:
TRANSPLANT SUPPORT ORGANIZATION
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 1154 Webster Avenue,NEW ROCHELLE,NY,USA 
ZIP Code:
Postal Code:
10804 
Telephone Number: 9146323500 (+1-914-632-3500) 
Fax Number:  
Website:
dellrealtycs. com 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
737415 
USA SIC Description:
Internet Service 
Number of Employees:
 
Sales Amount:
 
Credit History:
Credit Report:
 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
SECURE PATH NETWORKS LLC
GRAND HORIZON TOURS; INC
TLC MEDIA
Next company profile:
PREMIUM NISSAN
ATOLL K ENTERPRISES INC.
LEONARDO FEBBRARO










Company News:
  • Transplantation - World Health Organization (WHO)
    Initiated by the Fortieth World Health Assembly, the WHO Guiding principles on human cell, tissue and organ transplantation are a significant contribution to this area of health care, providing an orderly, ethical and acceptable framework for the acquisition and transplantation of human cells, tissues and organs for therapeutic purposes
  • Seventy-seventh World Health Assembly – Daily update: 30 May 2024
    Delegates approve groundbreaking new agreement on transplantation On 29 May 2024, Member States (with the initiation of Spain) approved a new resolution on increasing availability, ethical access and oversight of transplantation of human cells, tissues and organs
  • A seventh case of HIV cure reported at AIDS 2024
    The new case (1) presented at AIDS 2024 is a 60-year-old German man living with HIV who was diagnosed with acute myeloid leukaemia and underwent a blood stem cell transplant in 2015 from a donor with the CCR5-delta 32 mutation However, the stem cell donor had a single instead of a double CCR5-delta 32 mutation, which is an important difference
  • First case of HIV cure in a woman after stem cell transplantation . . .
    The International Maternal Pediatric Adolescent AIDS Clinical Trial Network (IMPAACT) P1107 reported the first case of HIV cure in a woman living with HIV submitted to a dual stem cell transplant (i e , an umbilical cord blood transplant combined with a half-matched bone marrow) for treatment of an acute myelogenous leukemia
  • WHO guiding principles on human cell, tissue and organ transplantation
    WHO guiding principles on human cell, tissue and organ transplantation - as endorsed by the sixty-third World Health Assembly in May 2010, in Resolution WHA63 22
  • WHO proposes global agenda on transplantation
    Reports on 'transplant tourism' show that it makes up an estimated 10% of global transplantation practices The phenomenon has been increasing since the mid-1990's, coinciding with greater acceptance of the therapeutic benefits of transplantation and with progress in the efficacy of the medicines - immuno-suppressants - used to prevent the body
  • Latent tuberculosis infection - World Health Organization (WHO)
    haematological transplant and patients with silicosis should be systematically tested and treated for LTBI (Strong recommendation, low–very low-quality evidence Updated recommendation) In countries with a low TB incidence, systematic testing for and treatment of LTBI may be considered for
  • Framework for establishing integrated kidney care programs in low- and . . .
    transplant can be unreasonably high in settings where pro-grams are new and or low numbers of transplants are per-formed One option for countries in this position could be to send patients who have a living donor abroad for the trans-plant procedure, with postoperative and chronic follow-up done locally This option will require development of
  • Autonomy in health decision-making - a key to recovery in mental health . . .
    Being able to make decisions about one’s life – including the right to choose one’s own mental Health care – is key to a person’s autonomy and personhood
  • Legionellosis - World Health Organization (WHO)
    The most susceptible hosts are immuno-compromised patients, including organ transplant recipients and cancer patients and those receiving corticosteroid treatment Delay in diagnosis and administration of appropriate antibiotic treatment, increasing age and presence of co-existing diseases are predictors of death from Legionnaires’ disease




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer